Systemic drug therapy in the obese patient with psoriasis

Should a patient’s Body Mass Index (BMI) influence the choice of a systemic drug in the treatment of psoriasis and psoriatic arthritis?  A recent report suggests that the answer is ‘Yes’1.

There is a strong and consistent association between obesity and psoriasis; obese patients are more likely to develop psoriasis and its severity increases with …

COVID- 19: A Point of View

Origins of the Virus

Most of the evidence now points towards a “wet” market in Wuhan, with bats being butchered for human consumption, the most likely source of COVID-19. These markets form an integral part of Chinese culture and social life.  And part of their tradition is to consume ‘warm meat’ – from animals that are killed on the spot (and…

Psoriasis and increased risk of migraine

In recent years, several large studies have found an association between psoriasis and migraine.  This is perhaps not entirely surprising, given that both conditions share several underlying mechanisms, connected with inflammation.  But how strong is the relationship and what implications does this have for the management of psoriatic patients? 

All in the mind - psoriasis and depression

It is well known that depression is common in those with psoriasis.  In fact, of all conditions that co-occur with psoriasis, depression is the most common, affecting up to 80% of patients with the condition1,2. Depression not only makes life miserable for sufferers; it increases the risk of psoriatic arthritis and worsens treatment outcomes and…

Show More